Evidence map›Paper›PMID 29991909›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2018

Distribution of

Olga Filiptsova, Marina Kobets, Julia Kobets, Olga Naboka, Olga Koiro, Alexandr Ochkur, Larisa Galiy

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Olga FiliptsovaBiology Department, National University of Pharmacy, Pushkinska Street, 53, Kharkov 61002, Ukraine.
Marina KobetsPharmaceutical Marketing and Management Department, National University of Pharmacy, Pushkinska Street, 53, Kharkov 61002, Ukraine.
Julia KobetsBiology Department, National University of Pharmacy, Pushkinska Street, 53, Kharkov 61002, Ukraine.
Olga NabokaBiology Department, National University of Pharmacy, Pushkinska Street, 53, Kharkov 61002, Ukraine.
Olga KoiroPharmacology Department, National University of Pharmacy, Pushkinska Street, 53, Kharkov 61002, Ukraine.
Alexandr OchkurPharmacognosy Department, National University of Pharmacy, Pushkinska Street, 53, Kharkov 61002, Ukraine.
Larisa GaliyPharmaceutical Marketing and Management Department, National University of Pharmacy, Pushkinska Street, 53, Kharkov 61002, Ukraine.
National University of Pharmacy · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CYP2B6 is one of the members of the cytochrome P450 superfamily. This enzyme metabolizes a number of currently prescribed drugs and different compounds. In light of clinical significance of the

Indexed as

CYP2B6 (516G/T) polymorphismPopulationUkraine

Identifiers

PMID29991909
PMCPMC6035515
OpenAlexW2793324212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.